Free Trial

Azenta (NASDAQ:AZTA) Reaches New 52-Week Low - Should You Sell?

Azenta logo with Medical background
Remove Ads

Shares of Azenta, Inc. (NASDAQ:AZTA - Get Free Report) hit a new 52-week low during trading on Thursday . The stock traded as low as $31.82 and last traded at $32.33, with a volume of 55500 shares trading hands. The stock had previously closed at $35.41.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Stephens restated an "overweight" rating and set a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd. Evercore ISI increased their target price on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Needham & Company LLC boosted their price target on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. Finally, TD Cowen upgraded Azenta to a "hold" rating in a research note on Thursday, February 27th.

Get Our Latest Research Report on AZTA

Azenta Stock Performance

The firm has a market cap of $1.29 billion, a P/E ratio of -9.45 and a beta of 1.66. The firm's fifty day simple moving average is $42.50 and its 200 day simple moving average is $45.58.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, equities research analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current year.

Remove Ads

Hedge Funds Weigh In On Azenta

Institutional investors have recently bought and sold shares of the business. Picton Mahoney Asset Management lifted its holdings in shares of Azenta by 305.7% in the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after acquiring an additional 532 shares during the last quarter. Headlands Technologies LLC purchased a new stake in Azenta during the fourth quarter valued at approximately $40,000. Covestor Ltd lifted its stake in shares of Azenta by 64.2% in the 4th quarter. Covestor Ltd now owns 2,043 shares of the company's stock valued at $102,000 after purchasing an additional 799 shares during the last quarter. KBC Group NV boosted its holdings in shares of Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after purchasing an additional 698 shares during the period. Finally, Quarry LP bought a new position in shares of Azenta during the 4th quarter valued at approximately $110,000. Institutional investors own 99.08% of the company's stock.

About Azenta

(Get Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

See Also

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads